p-Phenylenediamine induced DNA damage in SV-40 immortalized human uroepithelial cells and expression of mutant p53 and COX-2 proteins

Toxicology Letters

Volumn 170, Issue 2, 2007, Pages 116-123

  Huang, Ya Chun ^a   Hung, Wen Chun ^b   Kang, Wan Yi ^a,c   Chen, Wan Tzu ^a,c   Chai, Chee Yin ^a,b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cyclooxygenase; p Phenylenediamine; p53; Urothelial carcinoma

Indexed keywords

CYCLOOXYGENASE 2; PHENYLENEDIAMINE; PROTEIN P53;

ARTICLE; CARCINOGENESIS; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; EPITHELIUM CELL; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TRANSFORMED; CELL SURVIVAL; CELL TRANSFORMATION, VIRAL; COLORING AGENTS; COMET ASSAY; CYCLOOXYGENASE 2; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MUTAGENS; MUTATION; PHENYLENEDIAMINES; SIMIAN VIRUS 40; TUMOR SUPPRESSOR PROTEIN P53; UROTHELIUM;

EID: 34247381187     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2007.02.011     Document Type: Article

References (44)

1. Algaba F., Trias I., Santinelli A., and Montironi R. TP53 in urologic tumors. Anal. Quant. Cytol. Histol. 25 (2003) 123-130
2. Buckman S.Y., Gresham A., Hale P., Hruza G., Anast J., Masferrer J., and Pentland A.P. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 19 (1998) 723-729
3. Bush C., Price P., Norton J., Parkins C.S., Bailey M.J., Boyd J., Jones C.R., A'Hern R.P., and Horwich A. Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance. Br. J. Cancer 64 (1991) 357-360
4. Choi E.M., Kwak S.J., Kim Y.M., Ha K.S., Kim J.I., Lee S.W., and Han J.A. COX-2 inhibits anoikis by activation of the PI-3K/Akt pathway in human bladder cancer cells. Exp. Mol. Med. 37 (2005) 199-203
5. Cuendet M., and Pezzuto J.M. The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol. Drug Interact. 17 (2000) 109-157
6. Cunningham J., Lust J.A., Schaid D.J., Bren G.D., Carpenter H.A., Rizza E., Kovach J.S., and Thibodeau S.N. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res. 52 (1992) 1974-1980
7. Drobnjak M., Latres E., Pollack D., Karpeh M., Dudas M., Woodruff J.M., Brennan M.F., and Cordon-Cardo C. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J. Natl. Cancer Inst. 86 (1994) 549-554
8. Fairbairn D.W., Olive P.L., and O'Neill K.L. The Comet assay: a comprehensive review. Mutat. Res. 339 (1995) 37-59
9. Gago-Dominguez M., Castelao J.E., Yuan J.M., Yu M.C., and Ross R.K. Use of permanent hair dyes and bladder-cancer risk. Int. J. Cancer 91 (2001) 575-579
10. Garner R.C., and Nutman C.A. Testing of some azo dyes and their reduction products for mutagenicity using Salmonella typhimurium TA 1538. Mutat. Res. 44 (1977) 9-19
11. Hartge P., Hoover R., Altman R., Austin D.F., Cantor K.P., Child M.A., Key C.R., Mason T.J., Marrett L.D., Myers M.H., Narayana A.S., Silverman D.T., Sullivan J.W., Swanson G.M., Thomas D.B., and West D.W. Use of hair dyes and risk of bladder cancer. Cancer Res. 42 (1982) 4784-4787
12. HSDB. Hazardous Substance Data Base (HSDB, online database) National Library of Medicine (1991), Toxicology Information Program, Bethesda, MD
13. Kadlubar F.F. A transversion mutation hypothesis for chemical carcinogenesis by N2-substitution of guanine in DNA. Chem. Biol. Interact. 31 (1980) 255-263
14. Kam P.C., and See A.U. Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia 55 (2000) 442-449
15. Kelsey K.T., Hirao T., Hirao S., Devi-Ashok T., Nelson H.H., Andrew A., Colt J., Baris D., Morris J.S., Schned A., and Karagas M. TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer. Int. J. Cancer 117 (2005) 370-375
16. Komhoff M., Guan Y., Shappell H.W., Davis L., Jack G., Shyr Y., Koch M.O., Shappell S.B., and Breyer M.D. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am. J. Pathol. 157 (2000) 29-35
17. La Vecchia C., and Tavani A. Epidemiological evidence on hair dyes and the risk of cancer in humans. Eur. J. Cancer Prev. 4 (1995) 31-43
18. Lawrence N.S., Beckett E.L., Davis J., and Compton R.G. Voltammetric investigation of hair dye constituents: application to the quantification of p-phenylenediamine. Analyst 126 (2001) 1897-1900
19. Lianes P., Orlow I., Zhang Z.F., Oliva M.R., Sarkis A.S., Reuter V.E., and Cordon-Cardo C. Altered patterns of MDM2 and TP53 expression in human bladder cancer. J. Natl. Cancer Inst. 86 (1994) 1325-1330
20. Murata M., Nishimura T., Chen F., and Kawanishi S. Oxidative DNA damage induced by hair dye components ortho-phenylenediamines and the enhancement by superoxide dismutase. Mutat. Res. 607 (2006) 184-191
21. Nakopoulou L., Vourlakou C., Zervas A., Tzonou A., Gakiopoulou H., and Dimopoulos M.A. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Hum. Pathol. 29 (1998) 146-154
22. NTP. Bioassay of p-phenylenediamine dihydrochloride for possible carcinogenicity. Natl. Cancer Inst. Carcinog. Tech. Rep. Ser. 174 (1979) 1-107
23. Nzeako U.C., Guicciardi M.E., Yoon J.H., Bronk S.F., and Gores G.J. COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells. Hepatology 35 (2002) 552-559
24. Ohno Y., Aoki K., Obata K., and Morrison A.S. Case-control study of urinary bladder cancer in metropolitan Nagoya. Natl. Cancer Inst. Monogr. 69 (1985) 229-234
25. Ostling O., and Johanson K.J. Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem. Biophys. Res. Commun. 123 (1984) 291-298
26. Parfenova H., Parfenov V.N., Shlopov B.V., Levine V., Falkos S., Pourcyrous M., and Leffler C.W. Dynamics of nuclear localization sites for COX-2 in vascular endothelial cells. Am. J. Physiol. 281 (2001) C166-C178
27. Picardo M., Cannistraci C., Cristaudo A., De Luca C., and Santucci B. Study on cross-reactivity to the para group. Dermatologica 181 (1990) 104-108
28. Rauscher G.H., Shore D., and Sandler D.P. Hair dye use and risk of adult acute leukemia. Am. J. Epidemiol. 160 (2004) 19-25
29. Shahin M.M. Evaluation of the mutagenicity of azo dyes in Salmonella typhimurium: a study of structure-activity relationships. Mutagenesis 4 (1989) 115-125
30. Shirahama T. Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. Clin. Cancer Res. 6 (2000) 2424-2430
31. Singh N.P., and Wrenn M.E. Determinations of actinides in biological and environmental samples. Sci. Total Environ. 70 (1988) 187-203
32. Smith Pease C.K. From xenobiotic chemistry and metabolism to better prediction and risk assessment of skin allergy. Toxicology 192 (2003) 1-22
33. Sontag J.M. Carcinogenicity of substituted-benzenediamines (phenylenediamines) in rats and mice. J. Natl. Cancer Inst. 66 (1981) 591-602
34. Stanley L.A., Skare J.A., Doyle E., Powrie R., D'Angelo D., and Elcombe C.R. Lack of evidence for metabolism of p-phenylenediamine by human hepatic cytochrome P450 enzymes. Toxicology 210 (2005) 147-157
35. Subbaramaiah K., Altorki N., Chung W.J., Mestre J.R., Sampat A., and Dannenberg A.J. Inhibition of cyclooxygenase-2 gene expression by p53. J. Biol. Chem. 274 (1999) 10911-10915
36. Tang X., Sun Y.J., Half E., Kuo M.T., and Sinicrope F. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells. Cancer Res. 62 (2002) 4903-4908
37. Thun M.J., Altekruse S.F., Namboodiri M.M., Calle E.E., Myers D.G., and Heath Jr. C.W. Hair dye use and risk of fatal cancers in U.S. women. J. Natl. Cancer Inst. 86 (1994) 210-215
38. Tice R.R., and Strauss G.H. The single cell gel electrophoresis/Comet assay: a potential tool for detecting radiation-induced DNA damage in humans. Stem Cells 13 Suppl. 1 (1995) 207-214
39. Tong B.J., Tan J., Tajeda L., Das S.K., Chapman J.A., DuBois R.N., and Dey S.K. Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma. Neoplasia 2 (2000) 483-490
40. Trifan O.C., and Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J. Cell Mol. Med. 7 (2003) 207-222
41. Vainio H. Is COX-2 inhibition a panacea for cancer prevention?. Int. J. Cancer 94 (2001) 613-614
42. Van Duuren B.L. Carcinogenicity of hair dye components. J. Environ. Pathol. Toxicol. 3 (1980) 237-251
43. Vanderveen E.E., Grekin R.C., Swanson N.A., and Kragballe K. Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern. Arch. Dermatol. 122 (1986) 407-412
44. Yoshimura R., Sano H., Mitsuhashi M., Kohno M., Chargui J., and Wada S. Expression of cyclooxygenase-2 in patients with bladder carcinoma. J. Urol. 165 (2001) 1468-1472